Widespread evidence of viral miRNAs targeting host pathways

BMC Bioinformatics

Volumn 14, Issue , 2013, Pages

  Carl, Joseph W ^a   Trgovcich, Joanne ^b   Hannenhalli, Sridhar ^a  

^a Bldg 142   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; VIRUSES;

AXON GUIDANCES; BIOLOGICAL PROCESS; CELL DIFFERENTIATION; CELLULAR TARGETS; GENERAL PATTERNS; HUMAN CYTOMEGALOVIRUS; REGULATORY GENES; RNA MOLECULES;

RNA;

HUMAN HERPESVIRUS 5; INVERTEBRATA; MURINAE; MUS;

MICRORNA; VIRUS RNA;

ANIMAL; ARTICLE; BIOLOGY; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; NUCLEIC ACID DATABASE; PATHOGENICITY; VIRUS;

ANIMALS; COMPUTATIONAL BIOLOGY; CYTOMEGALOVIRUS; DATABASES, NUCLEIC ACID; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICE; MICRORNAS; RNA, VIRAL; VIRUSES;

EID: 84883492925     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-14-S2-S3     Document Type: Article

References (46)

1. Ambros V: microRNAs: tiny regulators with great potential. Cell 2001, 107(7):823-826.
2. Neilson JR, Sharp PA: Herpesviruses throw a curve ball: new insights into microRNA biogenesis and evolution. Nat Methods 2005, 2(4):252-254.
3. Carrington JC, Ambros V: Role of microRNAs in plant and animal development. Science 2003, 301(5631):336-338.
4. Ambros V: The functions of animal microRNAs. Nature 2004, 431(7006):350-355.
5. Sayed DAM: MicroRNAs in development and disease. Physiol Rev 2011, 91(3):827-887.
6. Ding SWVO: Antiviral immunity directed by small RNAs. Cell 2007, 130(3):413-426.
7. Otsuka MJQ, Georgel P, New L, Chen J, Mols J, Kang YJ, Jian Z, Du X, Cook R, Das SC, Pattnaik AK, Beutler B, Han J: Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 2007, 27(1):123-134.
8. Umbach JLKM, Jurak I, Karnowski HW, Coen DM, Cullen BR: MicroRNAs expressed by herpes simiplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454(7205):780-783.
9. Choy EYSK, Kok KH, Lung RW, Tsang CM, To KF, Kwong DL, Tsao SW, Jin DY: An Epstein-Barr virus encoded microRNA targets PUMA to promote host cell survival. J Exp Med 2008, 205(11):2551-2560.
10. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, Nusbaum JD, Feederle R, Delecluse H-J, Luftig MA, et al: The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines. PLoS Pathog 2012, 8(1):e1002484.
11. Alcami A, Koszinowski UH: Viral mechanisms of immune evasion. Immunology Today 2000, 21(9):447-455.
12. Horst DVM, Davison AJ, Ressing ME, Wiertz EJ: Viral evasion of T cell immunity: ancient mechanisms offering new applications. Current Opinion in Immunology 2011, 23(1):96-103.
13. Jiao JGH, Lippa AM, Ricciardi RP: The N terminus of adenovirus Type 12 E1A inhibits major histocompatibility complex class I expression by preventing phosphorylation of NF-kappaB p65 Ser276 through direct binding. Journal of virology 2010, 85(15):7668-7674.
14. Yee JWR, Anderton E, Allday MJ: Latent Epstein-Barr Virus Can Inhibit Apoptosis in B Cells by Blocking the Induction of NOXA Expression. PLoS One 2011, 6(12):e28506.
15. Blazara BAMA: Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1. Clin Exp Immunol 1990, 80(1):62-68.
16. Kropski JALW, Blackwell TS: Right Place, Right Time: The evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2012, 302:L441-L444.
17. Byzova TVGC, Jankau J, Chen J, Cabrera G, Achen MG, Stacker Sa, Carnevale KA, Siemionow M, Deitcher SR, DiCorleto PE: Adenovirus encoding vascular endothelial growth factor-D induces tissues specific vascular patterns in vivo. Blood 2002, 99(12):4434-4442.
18. Sharma-Walia NPA, Bottero V, Sadagopan S, Veettil MV, Kerur N, Chandran B: Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key fator in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog 2010, 6(2):e1000777.
19. Gao GLJ, Kong L, Tao L, Wei L: Human herpesvirus miRNAs statistically perferentially target host genes involved in cell signaling and adhesion/ junction pathways. Cell Research 2009, 19(5):665-667.
20. Samols MASR, Maldonado AM, Riva A, Lopez MC, Baker HV, Renne R: Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 2007, 3(5):e65.
21. Betel D, Koppal A, Agius P, Sander C, Leslie C: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biology 2010, 11(8):R90.
22. Kanehisa MGS: KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research 2000, 28(1):27-30.
23. Li SCSC, Lin WC: Vir-Mir db: prediction of viral microRNA candidate hairpins. Nucleic Acids Res 2008, 36:D184-D189.
24. Cai X, Schäfer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR: Epstein-Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed. PLoS Pathog 2006, 2(3):e23.
25. Cunningham CGD, Hilfrich B, Baluchova K, Dargan DJ, Thomson M, Griffiths PD, Wilkinson GW, Schulz TF, Davison AJ: Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. The Journal of general virology 2010, 91(Pt 3):605-615.
26. Thompson JDHD, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22(22):4673-4680.
27. Pfeffer SZM, Grässer FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T: Identification of virus-encoded microRNAs. Science 2004, 304(5671):734-736.
28. Liu PFX, Feng Z, Guo YM, Peng RJ, Liu T, Huang Z, Feng Y, Sun X, Xiong Z, Guo X, Pang SS, Wang B, Lv X, Feng FT, Li DJ, Chen LZ, Feng QS, Huang WL, Zeng MS, Bei JX, Zhang Y, Zeng YX: Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. Journal of virology 2011, 85(21):11291-11299.
29. Bloom DCSJ: Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. Journal of virology 1994, 68(6):3761-3772.
30. Lynch JPFM, Echavarria M: Adenovirus. Seminars in respiratory and critical care medicine 2011, 32(4):494-511.
31. Gottwein ECD, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR: Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 2011, 10(5):515-526.
32. Bartel DPCC: Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nature reviews Genetics 2004, 5(5):396-400.
33. Min HYS: Got target? Computational methods for microRNA target prediction and their extension. Experimental & molecular medicine 2010, 42(4):233-244.
34. Lovat FVN, Croce CM: MicroRNAs in the pathogenesis of cancer. Seminars in oncology 2011, 38(6):724-733.
35. Qin DFN, Fan W, Ma X, Yan Q, Lv Z, Zeng Y, Zhu J, Lu C: Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1. BMC microbiology 2011, 11.
36. Buchkovich NJYY, Zampieri CA, Alwine JC: The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway. Nature reviews Microbiology 2008, 6(4):266-275.
37. Fresno Vara JACE, de Castro J, Cejas P, Belda-Iniesta C, González-Barón M: PI3K/Akt signalling pathway and cancer. Cancer treatment reviews 2004, 30(2):193-204.
38. Lambert PJSA, Whitman AG, Dyson OF, Reber AJ, McCubrey JA, Akula SM: Targeting the PI3K and MAPK pathways to treat Kaposi's-sarcomaassociated herpes virus infection and pathogenesis. Expert opinion on therapeutic targets 2007, 11(5):589-599.
39. Buchkovich NJ, Maguire TG, Yu Y, Paton AW, Paton JC, Alwine JC: Human cytomegalovirus specifically controls the levels of the endoplasmic reticulum chaperone BiP/GRP78, which is required for virion assembly. J Virol 2008, 82(1):31-39.
40. Tzahar EMJ, Waterman H, Barbacci EG, Bao J, Levkowitz G, Shelly M, Strano S, Pinkas-Kramarski R, Pierce JH, Andrews GC, Yarden Y: Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. The EMBO journal 1998, 17(20):5948-5963.
41. Thomas MKRN, Lee JH, Habener JF: Hedgehog signaling regulation of insulin production by pancreatic beta-cells. Diabetes 2000, 49(12):2039-2047.
42. Pereira Tde AWR, Syn WK, Choi SS, Bradrick S, Karaca GF, Agboola KM, Jung Y, Omenetti A, Moylan CA, Yang L, Fernandez-Zapico ME, Jhaveri R, Shah VH, Pereira FE, Diehl AM: Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma. Laboratory investigation; a journal of technical methods and pathology 2010, 90(12):1690-1703.
43. Wilcox CLSR, Freed CR, Johnson EM Jr: Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci 1990, 10(4):1268-1275.
44. Saksena MMWH, Tijono B, Boadle RA, Rixon F, Takahashi H, Cunningham AL: Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons. Journal of virology 2006, 80(7):3592-3606.
45. Betel DKA, Agius P, Sander C, Leslie C: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 2010, 11(8):R90.
46. Benjamini Y, Hochberg Y: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995, 57(1):289-300.